Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing Local Government; it is a component of Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996 and initially function as the development and implementation of Beijing Government Grants Policy, BPBC serves as the focal point for advisory industrial policy, mandatory project management for government and international bridge between Chinese Biotech & Pharmaceutical Industry and the rest of the world. BPBC is composed of five divisions: Project Management, Strategy Study, Business Liaison and International Affairs, General Administration and Financial Management Divisions.
ABO at the BIO2008-Another Successful Round-Off on the Worldwide Biotech Stage
>> About Olympic Scientific Seminar [2008-07-16]
>> ChinaBio® Investor Forum [2008-06-18]
>> ABO PARTNERING MEETING (San Diego & San Francisco) at the BIO2008 [2008-07-17]
>> Beijing Attracted Eyeballs of World R&D Leaders’ [2007-03-28]
>> The investment status for bio-pharmaceutical industry in China. [2006-03-09]
>> Chinese Drug-maker Sanjiu eyes Kanebo unit. [2006-03-09]
>> China plan to import genetic modified corps from 4 foreign countries. [2006-03-09]
>> Bigwig in Chinese Vaccine Market—GSK. [2006-03-09]
>> Breakthrough in the scientific research on SARS virus genotype and SARS genic mutation rule in China [2006-03-09]
>> The protection to traditional Chinese medicine patent will be strengthened in China. [2006-03-09]